Skip to main content
Clinical Trials/KCT0005045
KCT0005045
Not yet recruiting
未知

Safety Of Laparoscopic or robotic radical hysterectomy Using endoscopic sTapler for Inhibiting tumOr spillage of cervical Neoplasms (SOLUTION): a phase II study

Seoul National University Hospital0 sites124 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of The genitoruinary system
Sponsor
Seoul National University Hospital
Enrollment
124
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional Study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • ? Females, aged 20 years or older
  • ? Histologically confirmed primary squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma of the uterine cervix
  • ? Patients with FIGO stage IB1 (FIGO staging 2009\)
  • : stromal invasion\>5 mm or 7 mm \<lesion size \=4 cm
  • ? Patients undergoing either type B or C hysterectomy (Querleu–Morrow classification)
  • ? Patients with normal bone marrow, renal and hepatic function
  • \- WBC \> 3\.0x10^9 cells/L
  • \- Platelets \> 100x10^9 cells/L
  • \- Serum creatinine \=1\.5 mg/dL
  • \- Serum total bilirubin \<1\.5 x normal range and AST/SGOT or ALT/SGPT \<3 x normal range

Exclusion Criteria

  • ? Any histological type other than squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma of the uterine cervix
  • ? Tumor size greater than 4 cm
  • ? Patients with FIGO less than stage IA2 or greater than IB2 (FIGO staging 2009\)
  • : stromal invasion \=5 mm and lesion size \=7 mm (less than IA2\)
  • : or lesion size\> 4 cm (greater than IB2\)
  • ? Patients with evidence of metastatic disease by conventional imaging studies, enlarged pelvic or aortic lymph nodes greater than 2 cm, or histologically positive lymph nodes
  • ? Patients in pregnancy
  • ? Patients with a history of pelvic or abdominal radiotherapy
  • ? Patients with contraindication of surgery (serious concomitant systemic disorders incompatible with the study to be decided at the discretion of the investigator)
  • ? Patients who agree to intra\-operative lymphatic mapping (IOLM) must not have:

Outcomes

Primary Outcomes

Not specified

Similar Trials